What commitments govern our pharmaceutical reference commissions and editorial agreements?

When did this editorial agreement take effect?

These terms took effect on October 16, 2026, and govern all website inquiries and editorial reference commissions submitted to Zavalorin on or after that date. Previous working drafts or superseded operational memoranda are rendered null upon publication of this instrument.

Any commission agreement active before October 16, 2026, remains subject to its signed project statement of work until completion, whereupon renewal or supplemental deliverables automatically transition to the provisions detailed here.

Who are you contracting with when commissioning reference materials?

You are contracting with Zavalorin, an independent healthcare reference practice and prescription reference documentation writer operating from 740 West Colfax Avenue, Denver, Colorado 80204, Denver, Colorado, United States.

Zavalorin has maintained continuous operations since 2021 as a professional editorial practice under lead editorial management with active membership in the Association of Health Care Journalists (AHCJ). The practice acts as an independent contractor, not an employee, agent, or clinical partner of commissioning clients.

What services does our practice provide and what falls outside our scope?

Zavalorin provides structured technical research, prescription drug monograph editor oversight, drug dosing guide content drafting, and patient medication instruction writing service deliverables for digital publications, specialty clinics, and healthcare websites.

Our work compiles and formats official prescribing documentation and peer-reviewed pharmacology journals into accessible educational formats. We do not provide clinical medical consultations, individual patient examinations, emergency triage, diagnosis, prescription issuance, or treatment plans.

The practice strictly declines commissions requesting personal diagnostic advice, alternative medical claims without compendial validation, deceptive marketing copy, or text implying that educational content replaces physician evaluation.

How does an inquiry through this website become a formal commission?

Nothing displayed on zavalorin.com constitutes a binding commercial offer or transactional purchase. All rate calculations and price cards published on this website are informal scoping estimates designed for budgetary planning.

A binding commission arises only after our Denver desk reviews your submitted outline, confirms source material availability, issues a formal written scope estimate, and both parties countersign a project statement of work. We reserve the right to decline any inquiry that fails our editorial ethics criteria or exceeds current production capacity.

What fee structures govern our drafting and verification work?

All fees are quoted and payable in United States Dollars (USD) according to confirmed operator price bands: prescription site reference pages are priced between 300 and 800 USD per page, patient medication instruction articles between 250 and 750 USD per piece, and specialized drafting between 100 and 150 USD per 100 words or 100 and 126 USD per hour.

Final quotes depend on four objective parameters: total manuscript length (typically 800 to 1,500 words for patient articles), required citation depth (inclusion of primary clinical trial registries versus standard package inserts), delivery turnaround (standard 2 to 5 business days versus 48-hour expedited schedules), and whether original clinical source data is provided by the client or assembled independently by our desk.

Standard engagements require a 50% initial retainer upon execution of the project statement, with the remaining balance due within 14 calendar days of draft delivery.

What restrictions govern the use of our website and consultation channels?

Visitors may access this website solely to review our reference practice capabilities, evaluate educational samples, run the price estimator tool, and submit legitimate editorial inquiries. You may not use automated scrapers or data crawlers to harvest our text or research assets without express written consent.

You agree not to bypass security controls, submit fabricated contact records, inject script payloads, flood the support chat channel, or manipulate form fields, including hidden honeypot validation inputs. Server and access logs are retained for 90 days. Support chat transcripts are retained for 6 months. Completed inquiry submissions and corresponding email transmissions are retained for 24 months. Consent preferences recorded under site_consent_v2 are retained for 12 months. Any formal data access request submitted to our desk is answered within 14 calendar days.

Who owns the research, source text, and completed reference deliverables?

All website text, custom graphic structures, brand marks, and layout implementations on zavalorin.com are the exclusive intellectual property of Zavalorin and are protected under United States and international copyright statutes.

For commissioned drafting deliverables: upon full receipt of the agreed contract fee, Zavalorin transfers exclusive publication rights for the finalized manuscript to the commissioning client. Zavalorin retains the perpetual, non-exclusive right to reference the project title and non-confidential excerpt samples in its professional portfolio and AHCJ accreditation dossiers.

Primary public domain source materials, including statutory FDA prescribing documentation and open-access PubMed registry citations, remain in the public domain and are not subject to proprietary claims.

What warranty and clinical disclaimers apply to our reference materials?

All reference guides, dosing tables, patient instruction drafts, and website contents are provided strictly for educational and informational purposes on an "as is" and "as available" basis. Zavalorin disclaims all implied warranties of merchantability or fitness for a specific diagnostic purpose.

Editorial Quality Warranty: Zavalorin warrants that all delivered copy has been cross-referenced against at least two primary authoritative pharmaceutical repositories (such as the FDA Orange Book, DailyMed, or peer-reviewed pharmacology journals) and that references trace to verifiable trial literature. If any factual discrepancy or citation error is identified within 30 days of draft delivery, our desk will revise and correct the text without additional fee within two business days.

Our work does not constitute medical advice and cannot substitute for clinical oversight by a licensed physician or pharmacist. Clients publishing our deliverables are solely responsible for verifying that their downstream presentation includes mandatory regulatory disclaimers and complies with applicable local healthcare advertising guidelines.

What limits govern our legal and financial liability?

To the maximum extent permitted under applicable law, Zavalorin, its lead editor, contributors, and independent contractors shall not be liable for any indirect, incidental, special, punitive, or consequential damages arising out of the use of this website, the reliance on reference drafts, or any downstream clinical decisions made by readers or third parties.

The aggregate financial liability of Zavalorin for any claim arising from a commissioning contract, whether sounding in contract, tort, negligence, or strict liability, shall be strictly capped at the total amount actually paid by the client to Zavalorin for the specific deliverable giving rise to the claim during the preceding twelve months.

Under what circumstances can a reference commission or website access be terminated?

Either party may terminate an active reference commission by providing written notice via email if the other party materially breaches contract terms and fails to remedy such breach within seven calendar days.

If a client cancels an ongoing assignment prior to draft completion for convenience, Zavalorin retains the non-refundable initial retainer to cover research hours and preliminary drafting. We reserve the immediate right to suspend or block website access and chat support for any user engaging in abusive communication or deceptive submissions.

What laws govern these terms and where are legal disputes resolved?

These terms, every scoping proposal, and all editorial commissions shall be governed by and construed in accordance with the substantive laws of the State of Colorado, United States, without giving effect to any principles of conflicts of law.

Any dispute or legal proceeding arising out of or relating to this agreement or our services shall be heard exclusively in the state or federal courts situated in Denver, Colorado. Both parties irrevocably consent to the personal jurisdiction and venue of such courts and waive any objection regarding inconvenient forum.

How will revisions or amendments to these editorial terms be announced?

Zavalorin periodically updates these terms to reflect evolving compendial citation protocols and regulatory operating standards. Google Ads, Microsoft Advertising, and Meta Ads direct paid referral traffic to this website. Referral traffic processes click identifiers including gclid for Google Ads, msclkid for Microsoft Advertising, and fbclid for Meta Ads. Under Google Consent Mode v2, the storage states ad_storage, ad_user_data, ad_personalization, and analytics_storage remain denied until a visitor affirmatively grants consent, and return to denied immediately upon declining. Global Privacy Control (Sec-GPC) signals are honored as an immediate opt-out. For Microsoft Advertising data processing terms, review the Microsoft Privacy Statement at https://privacy.microsoft.com/privacystatement.

Any modifications take effect immediately upon posting to this URL, with the updated date clearly reflected at the top of this document. Continued use of the website following publication of revised terms constitutes affirmative acceptance of the amendments.

How can you reach our Denver editorial desk with legal or commission questions?

For inquiries regarding these terms, contractual statements of work, copyright permissions, or scoping requests, contact our Denver editorial desk through any of the following verified channels: